Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Medical services industry

Article Abstract:

The stocks of medical services companies have risen, partly because of acquisitions and mergers. Continued growth is forecast for institutional pharmacies and assisted living facilities, which should experience annual growth of about 20% between 1997 and 2001. Drug companies must comply with new labelling regulations, which may affect sales of drugs intended for the elderly.

Author: Ferro, Mario, Feenan, Gerard, Clark, Charles, Markey, Keith A., O'Shea, Thomas M., Maher, John E., Bos, Robert J.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 1997
Health Care, Health Care and Social Assistance, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, HEALTH SERVICES, Management services, Office Administrative Services, Hospital Management, Drugs, Health care industry, Hospital management companies, Medical care, Oxford Health Plans Inc., OXHP, Aetna Inc., Apria Healthcare Group Inc., Beverly Enterprises Inc., Health Management Associates Inc., Humana Inc., Laboratory Corporation of America Holdings, Lincare Holdings Inc., Omnicare Inc., PacifiCare Health Systems Inc., Quorum Health Group Inc., Tenet Healthcare Corp., UnitedHealth Group Inc., WellPoint Health Networks Inc., BEV, COL, HMA, HRC, HUM, LH, LNCR, MNR, OCR, PHSYA, THC, WLP, HCA Inc., Hospital administration, UNIH, Multicare Companies Inc., MLTI, HealthSouth Corp., Manor Care Inc. (Silver Spring, Maryland), PhyCor Inc., Vencor Inc., Health Care and Retirement Corp., HealthCare COMPARE Corp., VC, HCR, HCCC, RoTech Medical Corp., ROTC, Caremark Therapeutic Services, MPTR, PHYC, APRA, NovaCare Inc., NOV

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

XenoPort, Inc

Article Abstract:

The price appreciation potential of the shares of XenoPort Inc. for the years 2010-2012 is discussed. The Santa Clara, California-based development-stage company is focused on treating neurological/psychiatric disorders and uses proprietary prodrug technology to facilitate absorption of orally administered compounds.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
XenoPort Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

NitroMed, Inc

Article Abstract:

The price appreciation potential of the shares of NitroMed Inc. for the years 2010-2012 is discussed. The Lexington, Massachusetts-based company offers nitric oxide-enhancing drugs, with the first product being used for the treatment of African Americans with heart failure.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
NitroMed Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Securities, Evaluation, Stock prices
Similar abstracts:
  • Abstracts: Pharmacy services industry. Alcon Inc
  • Abstracts: Electrical equipment industry. Hubbell Inc. 'B'. General Electric
  • Abstracts: Chemical (basic) industry. Dow Chemical
  • Abstracts: Food wholesalers industry. part 9
  • Abstracts: Entertainment technology industry. Guess, Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.